
Forward for Type 1 Diabetes: In the Spotlight
The Arch City Kids Theatre Troupe produces an annual Broadway-style musical revue to raise funds and awareness for type 1 diabetes.

Forward for Type 1 Diabetes: Reaching New Heights
Cameron Kenny has been infatuated with Mount Everest for as long as he can remember. He decided to make his big climb a fundraiser in honor of his brother.

Breakthrough T1D My Ride: A Journey with Purpose
Jennifer joined Breakthrough T1D My Ride to achieve her goal of a 100-mile bike ride and to fundraise in honor of her daughter, who lives with type 1 diabetes.

Gifts That Give Back
Giving to others has always been a hallmark of the holiday season and this year, you can spread joy by supporting the T1D community through gifts that give back and help drive Breakthrough T1D’s mission forward.

Forward for Type 1 Diabetes: Going the Distance
A cross-country motorcycle ride was on Guri Burmi's bucket list for a while. Using it to raise funds for type 1 diabetes research felt like a perfect fit.

Breakthrough T1D Is True Blue for National Diabetes Awareness Month
Fall is arriving in all its usual colors—orange, red, and…blue? Yes, National Diabetes Awareness Month is blue, and Breakthrough T1D has a lot happening in November!

The First Ride of Many
13-year-old Drew Salaki found a new community of support with Breakthrough T1D Ride, along with a newfound wisdom about living with type 1 diabetes (T1D).

ISPAD Annual Conference Highlights Include Tzield, Kidney Disease Clinical Trial Updates
Leading diabetes researchers gathered for the annual ISPAD conference. More than 45 studies were presented by Breakthrough T1D researchers, including Tzield.

Results Are Out: Tzield Benefits Newly Diagnosed Individuals
A new study published in the New England Journal of Medicine shows Tzield can preserve beta cell health in certain individuals recently diagnosed with T1D.

Insulin resistance and type 1 diabetes
We take a closer look at what insulin resistance is, the risks associated with it for people with type 1 diabetes, and the latest research to address it.